Clinical Trials · NCT03007329
Effects of Combined Dapagliflozin and Exenatide Versus Dapagliflozin and Placebo on Ectopic Lipids in Patients With Uncontrolled Type 2 Diabetes Mellitus.
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Medical University of Vienna
- Enrollment
- 34
- Start date
- Mar 2017
- Locations
- 1 site, Austria
- Primary endpoint
- change in hepatic lipid content measured with magnetic resonance spectroscopy in %